North Bridge Venture Partners
BS and PhD in Organic Chemistry, Duke University; postdoctoral National Science Foundation Fellowship, Harvard University; MBA, MIT Sloan School of Management. Formerly: in business development, GelTex Pharmaceuticals; in new product and business development, Dow Chemical (formerly Union Carbide Corporation); Co-Founder, President and Chief Executive Officer, Arsenal Medical; co-founded several other ventures, including Nano-Terra and 480 Biomedical. 2007, joined North Bridge Venture Partners; invests predominantly in companies that make products using chemistry, materials science and/or materials engineering, with a primary focus on early stage ventures. Co-Founder and Chairman, Diagnostics For All. Adviser: MIT's Deshpande Center for Technological Innovation; Harvard's Nanoscale Science and Engineering Center; schools of Science and Engineering, Duke University. Named one of the world's top 100 young entrepreneurs, MIT's Technology Review (1999).